Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-Hypertensive Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca
Daiichi Sankyo Company Limited
Pfizer
Sanofi
Johnson & Johnson
Novartis
Takeda Pharmaceutical
Lupin
Ranbaxy Laboratories
By Type:
Angiotensin Receptor Blockers (ARBs)
Alpha Blockers
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Calcium Channel Blockers
Renin Inhibitors
Beta Blockers
Vasodilators
By Application:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-Hypertensive Drugs Market Overview 2018-2029
-
1.1 China Anti-Hypertensive Drugs Industry Development Overview
-
1.2 China Anti-Hypertensive Drugs Industry Development History
-
1.3 China Anti-Hypertensive Drugs Industry Market Size (2018-2029)
-
1.4 China Anti-Hypertensive Drugs Market Analysis by Type from Production Side
-
1.4.1 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2029)
-
1.4.2 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Alpha Blockers (2018-2029)
-
1.4.3 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)
-
1.4.4 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2029)
-
1.4.5 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Calcium Channel Blockers (2018-2029)
-
1.4.6 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Renin Inhibitors (2018-2029)
-
1.4.7 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Beta Blockers (2018-2029)
-
1.4.8 China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Vasodilators (2018-2029)
-
1.5 China Anti-Hypertensive Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.2 China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.3 China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China Anti-Hypertensive Drugs Market Analysis by Region
-
1.6.1 North China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-Hypertensive Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-Hypertensive Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-Hypertensive Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-Hypertensive Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-Hypertensive Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-Hypertensive Drugs Industry Development
Chapter 3 Anti-Hypertensive DrugsIndustry Chain Analysis
-
3.1 Anti-Hypertensive Drugs Industry Chain
-
3.2 Anti-Hypertensive Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-Hypertensive Drugs Market
-
3.3 Anti-Hypertensive Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-Hypertensive Drugs Market
Chapter 4 China Anti-Hypertensive Drugs Market, by Type
-
4.1 China Anti-Hypertensive Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-Hypertensive Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-Hypertensive Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Angiotensin Receptor Blockers (ARBs)
-
4.5.2 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Alpha Blockers
-
4.5.3 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Diuretics
-
4.5.4 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors
-
4.5.5 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Calcium Channel Blockers
-
4.5.6 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Renin Inhibitors
-
4.5.7 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Beta Blockers
-
4.5.8 China Anti-Hypertensive Drugs Production Volume and Growth Rate of Vasodilators
Chapter 5 China Anti-Hypertensive Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-Hypertensive Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-Hypertensive Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Anti-Hypertensive Drugs Market Size and Growth Rate of Retail Pharmacies
-
5.5.2 China Anti-Hypertensive Drugs Market Size and Growth Rate of Hospital Pharmacies
-
5.5.3 China Anti-Hypertensive Drugs Market Size and Growth Rate of Online Pharmacies
Chapter 6 China Anti-Hypertensive Drugs Market, by Region
-
6.1 China Anti-Hypertensive Drugs Production Volume and Production Value, by Region
-
6.2 China Anti-Hypertensive Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-Hypertensive Drugs Market Analysis
-
7.1 North China Anti-Hypertensive Drugs Market, by Type
-
7.2 North China Anti-Hypertensive Drugs Market, by Application
Chapter 8 Central China Anti-Hypertensive Drugs Market Analysis
-
8.1 Central China Anti-Hypertensive Drugs Market, by Type
-
8.2 Central China Anti-Hypertensive Drugs Market, by Application
Chapter 9 South China Anti-Hypertensive Drugs Market Analysis
-
9.1 South China Anti-Hypertensive Drugs Market, by Type
-
9.2 South China Anti-Hypertensive Drugs Market, by Application
Chapter 10 East China Anti-Hypertensive Drugs Market Analysis
-
10.1 East China Anti-Hypertensive Drugs Market, by Type
-
10.2 East China Anti-Hypertensive Drugs Market, by Application
Chapter 11 Northeast China Anti-Hypertensive Drugs Market Analysis
-
11.1 Northeast China Anti-Hypertensive Drugs Market, by Type
-
11.2 Northeast China Anti-Hypertensive Drugs Market, by Application
Chapter 12 Southwest China Anti-Hypertensive Drugs Market Analysis
-
12.1 Southwest China Anti-Hypertensive Drugs Market, by Type
-
12.2 Southwest China Anti-Hypertensive Drugs Market, by Application
Chapter 13 Northwest China Anti-Hypertensive Drugs Market Analysis
-
13.1 Northwest China Anti-Hypertensive Drugs Market, by Type
-
13.2 Northwest China Anti-Hypertensive Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Profile
-
14.1.2 AstraZeneca Anti-Hypertensive Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Daiichi Sankyo Company Limited
-
14.2.1 Daiichi Sankyo Company Limited Company Profile
-
14.2.2 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Anti-Hypertensive Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Sanofi
-
14.4.1 Sanofi Company Profile
-
14.4.2 Sanofi Anti-Hypertensive Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Profile
-
14.5.2 Johnson & Johnson Anti-Hypertensive Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis
-
14.6.1 Novartis Company Profile
-
14.6.2 Novartis Anti-Hypertensive Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Takeda Pharmaceutical
-
14.7.1 Takeda Pharmaceutical Company Profile
-
14.7.2 Takeda Pharmaceutical Anti-Hypertensive Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Lupin
-
14.8.1 Lupin Company Profile
-
14.8.2 Lupin Anti-Hypertensive Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Ranbaxy Laboratories
-
14.9.1 Ranbaxy Laboratories Company Profile
-
14.9.2 Ranbaxy Laboratories Anti-Hypertensive Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-Hypertensive Drugs Industry Research Conclusions
-
15.2 Anti-Hypertensive Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-Hypertensive Drugs Industry Market Size (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Alpha Blockers (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Calcium Channel Blockers (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Renin Inhibitors (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Beta Blockers (2018-2029)
-
Figure China Anti-Hypertensive Drugs Production Volume, Production Value and Growth Rate of Vasodilators (2018-2029)
-
Figure China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Anti-Hypertensive Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-Hypertensive Drugs Market Size and Growth Rate from 2018-2029
-
Figure Anti-Hypertensive Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-Hypertensive Drugs Market Share by Type in 2018
-
Figure China Anti-Hypertensive Drugs Market Share by Type in 2023
-
Figure China Anti-Hypertensive Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Alpha Blockers (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Diuretics (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Calcium Channel Blockers (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Renin Inhibitors (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Beta Blockers (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume and Growth Rate of Vasodilators (2018-2023)
-
Figure China Anti-Hypertensive Drugs Market Share by Application in 2018
-
Figure China Anti-Hypertensive Drugs Market Share by Application in 2023
-
Figure China Anti-Hypertensive Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-Hypertensive Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Anti-Hypertensive Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Anti-Hypertensive Drugs Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China Anti-Hypertensive Drugs Production Volume by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Production Volume Share by Region (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Volume Share by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Production Value by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Production Value Share by Region (2018-2023)
-
Figure China Anti-Hypertensive Drugs Production Value Share by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Sales Volume by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Anti-Hypertensive Drugs Sales Volume Share by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Sales Value by Region (2018-2023)
-
Table China Anti-Hypertensive Drugs Sales Value Share by Region (2018-2023)
-
Figure China Anti-Hypertensive Drugs Sales Value Share by Region (2018-2023)
-
Table North China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table North China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table North China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table North China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table Central China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table Central China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table South China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table South China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table South China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table East China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table East China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table East China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-Hypertensive Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-Hypertensive Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-Hypertensive Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-Hypertensive Drugs Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company Limited Company Profile
-
Table Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Profile
-
Table Takeda Pharmaceutical Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Lupin Company Profile
-
Table Lupin Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
Table Ranbaxy Laboratories Company Profile
-
Table Ranbaxy Laboratories Anti-Hypertensive Drugs Revenue, Price and Gross (2018-2023)
-
